Malignant mixed mesodermal tumours: biology and clinical aspects. 2002

C Gourley, and A Al-Nafussi, and M Abdulkader, and J F Smyth, and H Gabra
ICRF Medical Oncology Unit, MRC Building, Western General Hospital, EH4 2XU, Edinburgh, UK. charles.gourley@cancer.org.uk

Mixed mesodermal tumours (MMTs) are relatively rare gynaecological tumours that have been poorly studied in clinical and molecular terms. They are chemosensitive (at least initially), although ultimately they have a poor prognosis. The biology of the tumour is fascinating in view of its composition of both epithelial and mesenchymal entities. We review herein the literature on the clinical and biological aspects of this malignancy.

UI MeSH Term Description Entries
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females
D005833 Genital Neoplasms, Female Tumor or cancer of the female reproductive tract (GENITALIA, FEMALE). Gynecologic Neoplasms,Female Genital Neoplasms,Neoplasms, Female Genital,Neoplasms, Gynecologic,Female Genital Neoplasm,Genital Neoplasm, Female,Gynecologic Neoplasm,Neoplasm, Female Genital,Neoplasm, Gynecologic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D018198 Mixed Tumor, Malignant A malignant tumor composed of more than one type of neoplastic tissue. (Dorland, 27th ed) Malignant Mixed Tumor,Malignant Mixed Tumors,Mixed Tumors, Malignant,Tumor, Malignant Mixed,Tumors, Malignant Mixed
D018199 Mixed Tumor, Mesodermal A sarcoma of the body of the uterus arising in older women, composed of more than one mesenchymal tissue, especially including striated muscle cells. It is associated with previous pelvic radiation exposure in 20% of patients. (Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1702) Mesodermal Mixed Tumor,Mesodermal Mixed Tumors,Mixed Tumors, Mesodermal,Tumor, Mesodermal Mixed,Tumors, Mesodermal Mixed

Related Publications

C Gourley, and A Al-Nafussi, and M Abdulkader, and J F Smyth, and H Gabra
April 1990, Journal of clinical pathology,
C Gourley, and A Al-Nafussi, and M Abdulkader, and J F Smyth, and H Gabra
March 1991, Journal of surgical oncology,
C Gourley, and A Al-Nafussi, and M Abdulkader, and J F Smyth, and H Gabra
July 1972, The Medical journal of Australia,
C Gourley, and A Al-Nafussi, and M Abdulkader, and J F Smyth, and H Gabra
January 1967, The Journal of pathology and bacteriology,
C Gourley, and A Al-Nafussi, and M Abdulkader, and J F Smyth, and H Gabra
May 1961, American journal of obstetrics and gynecology,
C Gourley, and A Al-Nafussi, and M Abdulkader, and J F Smyth, and H Gabra
February 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
C Gourley, and A Al-Nafussi, and M Abdulkader, and J F Smyth, and H Gabra
November 1991, Gynecologic oncology,
C Gourley, and A Al-Nafussi, and M Abdulkader, and J F Smyth, and H Gabra
October 1985, European journal of obstetrics, gynecology, and reproductive biology,
C Gourley, and A Al-Nafussi, and M Abdulkader, and J F Smyth, and H Gabra
April 1958, The Journal of obstetrics and gynaecology of the British Empire,
C Gourley, and A Al-Nafussi, and M Abdulkader, and J F Smyth, and H Gabra
September 1992, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
Copied contents to your clipboard!